Preliminary Scientific Programme
Thursday, January 30, 2025
Opening
| Time | Presentation Title | Speaker |
| 08:30-08:45 |
Opening & Objectives
|
Paola Anna Erba Sofia C. Vaz Karolien Goffin |
Thursday, January 30, 2025
Assessing Suspicious Breast Lesions With Imaging (T&N Staging)
Chairpersons: TBC
| Time | Presentation Title | |
| 08:47-09:05 | Essential Information Needed for Clinical Decision | |
| 09:08-09:26 | State of the Art in Pathology | |
| 09:29-09:47 | Optimal Diagnosis of Breast Cancer With Radiologic Imaging (T & N Staging) | |
| 09:50-10:08 | Indications for Molecular Breast Imaging (Scintigraphy and PET) | |
| 10:11-10:29 |
Expectations from Lymphoscintigraphy and Imaging-Guided Surgery
|
|
| 11:00-11:15 | Controversy: How to Position Molecular Imaging in Evaluating Breast Lesions? | |
| 11:16-11:23 |
In Favour
|
|
| 11:24-11:31 |
Against
|
|
| 11:32-11:47 | The Surgeon’s Perspective | |
| 11:48-11:58 |
Questions & Answers
|
|
| 12:00-13:00 |
Consensus on Imaging for Suspicious Breast Lesions (T&N Staging)
|
Thursday, January 30, 2025
Baseline Systemic Staging of Breast Cancer (M Staging)
Chairpersons: TBC
| Time | Presentation Title | |
| 14:00-14:20 | How Can Conventional Imaging Help in Clinical Decision | |
| 14:21-14:41 | Indications for PET with FDG | |
| 14:42-15:02 | Indications for PET with FES | |
| 15:03-15:18 | Molecular Characterization with wbMRI (Special Clinical Needs & Bone Assessment) | |
| 15:19-15:35 |
‘In Vivo’ Molecular Characterization Using PET
|
|
| 16:00-16:15 | Controversy: Is it Time to Include Tumour-Specific Tracers in Breast Cancer Staging? | |
| 16:16-16:23 |
In Favour
|
|
| 16:24-16:31 |
Against
|
|
| 16:32-16:47 |
The Oncologist’s Perspective
|
|
| 16:48-16:58 |
Questions & Answers
|
|
| 17:00-18:00 |
Consensus on Imaging for Baseline Systemic Staging of Breast Cancer (M Staging)
|
Friday, January 31, 2025
Assessing Systemic Treatment Response with Imaging
Chairpersons: TBA
| Time | Presentation Title | |
| 09:00-09:18 | Clinical Assessment of Treatment Response in Early Breast Cancer | |
| 09:20-09:38 | Imagiological Assessment of Treatment Response in Early Breast Cancer | |
| 09:40-09:58 | Clinical Assessment of Treatment Response in Advanced Breast Cancer | |
| 10:00-10:18 | Radiological Criteria to Assess Treatment Response in Advanced Breast Cancer | |
| 10:20-10:35 | PET in Assessing Treatment Response in Advanced Breast Cancer | |
| 11:00-11:15 | Controversy: Is FDG PET/CT Ready to Assess Therapy Response? | |
| 11:16-11:23 | In Favour | |
| 11:24-11:31 | Against | |
| 11:32-11:47 | The Oncologist’s Perspective | |
| 11:48-12:58 | Questions & Answers | |
| 12:00-13:00 | Consensus on Imaging for Assessing Systemic Treatment Response |
Friday, January 31, 2025
Assessing Systemic Recurrence with Imaging
Chairpersons: TBA
| Time | Presentation Title | |
| 14:00-14:20 | When to Suspect Tumour Recurrence | |
| 14:25-14:45 | The Challenge of Oligometastatic Disease | |
| 14:50-15:10 | Assessing Recurrence with Conventional Imaging | |
| 15:15-15:35 | Assessing Recurrence with PET/CT and PET/MRI | |
| 16:00-16:15 | Controversy: Is PET Ready to Assess Recurrence in all Breast Cancer Subtypes? | |
| 16:16-16:23 |
In Favour
|
|
| 16:24-16:31 | Against | |
| 16:32-16:47 | The Oncologist’s Perspective | |
| 16:48-16:58 | Questions & Answers | |
| 17:00-18:00 | Consensus on Imaging for Assessing Breast Cancer Systemic Recurrence |
Saturday, February 1, 2025
Future Imaging Challenges & Developments in Breast Cancer
Chairpersons: TBA
| Time | Presentation Title | |
| 09:00-09:15 | Expectations Towards a More Patient-Centred Approach | |
| 09:17-09:35 | The Most Promising New Biological Targets | |
| 09:37-09:55 | New Targets Used in Radiopharmaceuticals | |
| 09:57-10:15 | Bone Pain Palliation & Theranostics Possibilities | |
| 10:17-10:35 | Impact of PET-based Radiation Therapy Planning | |
| 10:37-10:52 | Controversy: What Is Still Needed to Move Theranostics Further in Breast Cancer? | |
| 11:15-12:15 | Overall Consensus | |
| 12:15-12:30 | Consensus on ‘Relevant Factors to Build a Consensus’ | |
| 12:30-12:50 | Summary of Results and Debate with All Participants | |
| 12:50-13:00 | Future Directions & Closing Remarks |